Trial Details

COMPLETED
Basic Information
Clinical ID c913
Identifier NCT05896943
Trial Title The Application of Transcriptomics in the Treatment of Ulcerative Colitis With Ustekinumab
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Ulcerative Colitis
Interventions DRUG: Ustekinumab
Participant Information
Sponsor Evangelismos Hospital
City Athens
Country/Region Greece
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type OBSERVATIONAL
Phase -
Time Information
Start Date 2022-04-01
Primary Completion Date 2023-10-31
Completion Date 2024-09-25